What is the Nephrocare Health Services Ltd share price today?

The share price of NSE:NEPHROPLUS-EQ on 07 Sep 2026 (as of 10:59:52 IST) is ₹703.80.

What is the NSE:NEPHROPLUS-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:NEPHROPLUS-EQ 52 week high low range shows a high of ₹769.75 and a low of ₹446.00.

What is the Nephrocare Health Services Ltd market cap?

As on 07 Sep 2026, Nephrocare Health Services Ltd market cap is ₹7012.48 Cr.

What is the shareholding pattern of Nephrocare Health Services Ltd Stock?

The shareholding pattern of Nephrocare Health Services Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.85% Foreign Institutional Investors (FII): 8.78% Domestic Institutional Investors (DII): 5.85% Mutual Funds: 3.20% Retail & Others: 18.32% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Nephrocare Health Services Ltd?

The Price-to-Earnings (PE) ratio of Nephrocare Health Services Ltd is 91.26, and the Price-to-Book (PB) ratio is 4.62, as on 07 Sep 2026.

Nephrocare Health Services Share Price

751.60+8.25 (+1.11%)

+59.49% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.11%

1 Week

+2.23%

1 Month

+8.28%

3 Month

+8.90%

6 Month

+41.49%

YTD

+60.36%

1 Year

5 Year

10 Year

Max

+53.39%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

735.20

730.55

669.00

618.00

501.85

446.00

High

759.80

781.50

About

Nephrocare Health Services is engaged in offering comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

FORTISNSE

ASTERDMNSE

MEDANTANSE

NHNSE

KIMSNSE

LALPATHLABNSE

VIJAYANSE

NEPHROPLUSNSE

LTP

1W Low

1W High

Market cap (₹)

8912+215.5 (2.48%)

8686.50

8974.50

1,26,103Cr

1066.6+41.6 (4.06%)

1021.10

1072.60

1,02,684Cr

747.15+32.55 (4.55%)

711.70

751.30

97,128Cr

893.5+23.2 (2.67%)

874.35

906.50

66,059Cr

756.75+15.55 (2.10%)

738.05

770.50

65,885Cr

1504.9+100.3 (7.14%)

1404.20

1527

40,512Cr

1896.9+45.3 (2.45%)

1848.30

1940

39,437Cr

788.85+22.2 (2.90%)

763.05

819

34,063Cr

1902.3+6.6 (0.35%)

1885

1959.40

31,822Cr

1556.1+117.8 (8.19%)

1423.30

1573.90

16,042Cr

751.15+15.95 (2.17%)

730.55

759.80

7,478Cr

Nephrocare Health Services Share Price

751.60+8.25 (+1.11%)

+59.49% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years32%

Last year32%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year15%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years7%

5 years7%

3 years11%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	32%	32%
-	-	-	15%
-	-	-	-
7%	7%	11%	9%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

FORTIS

ASTERDM

MEDANTA

KIMS

LALPATHLAB

VIJAYA

NEPHROPLUS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
8,912	₹126103 Cr	60.35	40.39	207.67	₹1942 Cr
1,066.6	₹102684 Cr	70.48	3.31	19.84	₹1442 Cr
747.15	₹97128 Cr	108.85	1.96	11.95	₹892 Cr
893.5	₹66059 Cr	63.04	3.53	20.1	₹1042 Cr
756.75	₹65885 Cr	206.75	0.31	6.76	₹388 Cr
1,504.9	₹40512 Cr	72.84	5.91	29.85	₹556 Cr
1,896.9	₹39437 Cr	48.32	10.14	65.36	₹806 Cr
788.85	₹34063 Cr	166.73	1.04	12.74	₹241 Cr
1,902.3	₹31822 Cr	58.72	10.11	42.51	₹505 Cr
1,556.1	₹16042 Cr	85.56	5.16	27.53	₹173 Cr
751.15	₹7478 Cr	97.32	3.19	16.66	₹77 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Jun 2025	Mar 2025	Dec 2024
₹282 Cr	₹266 Cr	₹260 Cr	₹228 Cr	₹219 Cr	₹197 Cr
₹7 Cr	₹12 Cr	₹3 Cr	₹7 Cr	₹4 Cr	₹5 Cr
₹289 Cr	₹277 Cr	₹263 Cr	₹234 Cr	₹223 Cr	₹203 Cr
₹242 Cr	₹238 Cr	₹221 Cr	₹200 Cr	₹187 Cr	₹171 Cr
₹71 Cr	₹65 Cr	₹64 Cr	₹54 Cr	₹55 Cr	₹49 Cr
₹2 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr
₹45 Cr	₹36 Cr	₹36 Cr	₹29 Cr	₹30 Cr	₹26 Cr
₹36 Cr	₹33 Cr	₹32 Cr	₹24 Cr	₹25 Cr	₹20 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹20 Cr	₹5 Cr	₹5 Cr	₹5 Cr
₹18 Cr	₹13 Cr	₹6 Cr	₹8 Cr
₹1078 Cr	₹566 Cr	₹402 Cr	₹375 Cr
₹1078 Cr	₹566 Cr	₹402 Cr	₹375 Cr
₹1116 Cr	₹584 Cr	₹414 Cr	₹389 Cr
₹5 L	₹96 Cr	₹123 Cr	₹81 Cr
-₹30 Cr	-₹19 Cr	-₹23 Cr	-₹17 Cr
₹46 Cr	₹26 Cr	₹23 Cr	₹17 Cr
₹6 Cr	₹5 Cr	₹3 Cr	₹4 Cr
₹21 Cr	₹108 Cr	₹126 Cr	₹86 Cr
—	—	—	—
₹143 Cr	₹113 Cr	₹71 Cr	₹43 Cr
₹124 Cr	₹63 Cr	₹78 Cr	₹38 Cr
₹13 Cr	₹101 Cr	₹93 Cr	₹92 Cr
₹19 Cr	₹7 Cr	₹1 Cr	₹1 Cr
₹299 Cr	₹284 Cr	₹243 Cr	₹175 Cr
₹1437 Cr	₹976 Cr	₹782 Cr	₹650 Cr
₹23 Cr	₹226 Cr	₹243 Cr	₹196 Cr
—	—	—	—
₹841 Cr	₹679 Cr	₹564 Cr	₹386 Cr
₹323 Cr	₹282 Cr	₹208 Cr	₹146 Cr
₹1 Cr	₹0	₹0	₹0
₹517 Cr	₹396 Cr	₹356 Cr	₹239 Cr
₹6 Cr	₹6 Cr	₹69 L	₹32 Cr
₹7 Cr	₹0	₹0	₹0
₹7 Cr	₹0	₹0	₹0
₹23 Cr	₹10 Cr	₹16 Cr	₹10 Cr
₹46 Cr	₹18 Cr	₹20 Cr	₹42 Cr
₹598 Cr	₹431 Cr	₹392 Cr	₹325 Cr
—	—	—	—
₹171 Cr	₹51 Cr	₹0	₹0
₹33 Cr	₹27 Cr	₹26 Cr	₹26 Cr
₹317 Cr	₹266 Cr	₹203 Cr	₹159 Cr
₹255 Cr	₹155 Cr	₹61 Cr	₹14 Cr
₹8 Cr	₹6 Cr	₹7 Cr	₹4 Cr
₹56 Cr	₹40 Cr	₹94 Cr	₹121 Cr
₹839 Cr	₹545 Cr	₹390 Cr	₹324 Cr
₹540 Cr	₹261 Cr	₹147 Cr	₹150 Cr
₹1437 Cr	₹976 Cr	₹782 Cr	₹650 Cr
₹109	₹3,217	₹2,310	₹2,167
₹109	₹643	₹462	₹433

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹97 Cr	₹87 Cr	₹33 Cr	-₹9 Cr
₹168 Cr	₹93 Cr	₹80 Cr	₹69 Cr
-₹6 Cr	-₹44 Cr	-₹33 Cr	-₹53 Cr
₹260 Cr	₹136 Cr	₹80 Cr	₹7 Cr
₹233 Cr	₹135 Cr	₹72 Cr	₹11 Cr
-₹410 Cr	-₹125 Cr	-₹51 Cr	-₹78 Cr
₹157 Cr	₹54 Cr	₹27 Cr	₹60 Cr
-₹21 Cr	₹65 Cr	₹48 Cr	-₹7 Cr
₹126 Cr	₹61 Cr	₹14 Cr	₹19 Cr
₹19 Cr	₹2 L	-₹1 Cr	₹2 Cr
₹124 Cr	₹126 Cr	₹61 Cr	₹14 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Nephrocare Health Services Share Price

751.60+8.25 (+1.11%)

+59.49% past 1 Year

Shareholding summary

Promoters

63.85%

FII

8.78%

DII

5.85%

3.2%

Others

18.32%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025
63.85%	63.85%	63.85%
8.78%	9.94%	3.59%
5.85%	5.47%	4.31%
3.20%	3.17%	3.44%
18.32%	17.57%	24.81%

Bulk & block deals

Name

Polar Capital Funds Plc-Healthcare Opportunities Fund

Poonawalla Vision Fund I

Mansi Share And Stock Broking Private Limited

Marwadi Chandarana Intermediaries Brokers Private Limited

Rajasthan Global Securities Pvt Ltd

Mansi Share And Stock Broking Private Limited

Rajasthan Global Securities Pvt Ltd

Marwadi Chandarana Intermediaries Brokers Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
17 Dec 2025	Purchase	165.14 Cr	₹481.77	34.28 L	Bulk	3.416227	NSE
17 Dec 2025	Purchase	29.89 Cr	₹490.05	6.10 L	Bulk	0.607929	NSE
17 Dec 2025	Purchase	27.93 Cr	₹490	5.70 L	Bulk	0.568085	NSE
17 Dec 2025	Purchase	25.78 Cr	₹482.75	5.34 L	Bulk	0.532182	NSE
17 Dec 2025	Purchase	2.46 Cr	₹491	50 K	Bulk	0.04983	NSE
17 Dec 2025	Sell	27.55 Cr	₹483.30	5.70 L	Bulk	0.568085	NSE
17 Dec 2025	Sell	25.50 Cr	₹490.10	5.20 L	Bulk	0.518614	NSE
17 Dec 2025	Sell	23.36 Cr	₹477.65	4.89 L	Bulk	0.487335	NSE

Insider trading & SAST

Client name

Polar Capital Funds Plc & Others

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
19 Jan 2026	Other	Acquisition	0.21	5.05	0	—	2.14 L	19 Dec 2025	Market	50,74,256	SAST	29(1)	—

Nephrocare Health Services Share Price

751.60+8.25 (+1.11%)

+59.49% past 1 Year

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

5th Floor, D Block Ilabs Centre, Plot 18, Software Units Layout Survey No. 64, Madhapur, Shaikpet Hyderabad Telangana PIN: 500081 Tel No: 040 4240 8039 Fax No: NULL Email: [email protected] Internet: www.nephroplus.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Kishore Kathri, Head Legal, Company Secretary & Compliance Officer

Vikram Vuppala, Chairman & Managing Director

Om Prakash Manchanda, Non Executive Independent Director

Hemant Sultania, Non Executive Independent Director

Ajay Bakshi, Non Executive Independent Director

Vishal Vijay Gupta, Nominee Director

Gaurav Sharma, Nominee Director

Sunil Kumar Thakur, Nominee Director

Annette Berit Ingrid Kumlien, Non Executive Independent Director

Details

Nephrocare Health Services Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Nephrocare Health Services Share Price

Nephrocare Health Services Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Nephrocare Health Services Share Price

Nephrocare Health Services Share Price

Oscillators

Moving averages

Nephrocare Health Services Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Nephrocare Health Services Share Price

Corporate Actions

Company details

Nephrocare Health Services Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Nephrocare Health Services Share Price

News

Nephrocare Health to acquire dialysis facility assets in the Philippines

Nephrocare Health buys full ownership of Almaty dialysis centre

Nephrocare Health reiterates medium term growth outlook of 15 to 20 percent

Nephrocare Health Services reports higher Q1 EBITDA and stable margin

Nephrocare Health Services reports Q1 revenue growth to Rs 280 crores

Nephrocare Health Services reports higher Q1 net profit year on year

Nephrocare Health Services sees Rs 70 crore block trade in NEPHROPLUS stock

Nephrocare Health Services to acquire Philippines dialysis center assets

Nephrocare Health trades higher on the BSE

Nephrocare Health shines as its arm inks asset transfer pact with Amica Healthcare System Corporation

Nephrocare Health’s arm inks asset transfer pact with Amica Healthcare System Corporation

Nephrocare Health arm acquires Philippines dialysis assets to expand global footprint

Nephrocare Health jumps as its arm inks asset transfer pact with Inocentes Dialysis Clinic

Nephrocare Health’s arm inks asset transfer pact with Inocentes Dialysis Clinic

Nephrocare Health Services unit signs asset transfer deal with Inocentes Dialysis Clinic

Nephrocare Health Services rises as its arm incorporates wholly-owned subsidiary in Kazakhstan

Nephrocare Health Services’ arm incorporates wholly-owned subsidiary in Kazakhstan

Nephrocare Health Se - Quaterly Results

Nephrocare Health Services planned Rs 10 crore investment in Nepal unit

Nephrocare Health Services reported Q4 EBITDA growth but margin contraction YoY

Nephrocare Health Services Ltd Share Price Today

Nephrocare Health Services Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator